Jump to main content
eTG Complete
Index
Search
Home
Addiction
Cannabis: hazardous, harmful and dependent use
Harm reduction in cannabis use
Addiction
What is covered in the Addiction guidelines?
Overview of substance use and addictive behaviours
Tobacco smoking and nicotine dependence
Alcohol: hazardous, harmful and dependent use
Opioids: hazardous, harmful and dependent use
Benzodiazepines, zolpidem and zopiclone: hazardous, harmful and dependent use
Cannabis: hazardous, harmful and dependent use
Overview of disorders of cannabis use
Screening and assessment of cannabis use
Overview of management of disorders of cannabis use
Brief interventions for management of disorders of cannabis use
Gradual reduction of cannabis use
Cannabis withdrawal
Psychosocial interventions for long-term management of disorders of cannabis use
Harm reduction in cannabis use
Overview of harm reduction in cannabis use
Management of disorders of cannabis use in specific populations
Further reading for cannabis: harmful, hazardous and dependent use
References
Gamma-hydroxybutyrate (GHB): hazardous, harmful and dependent use
Hallucinogens: hazardous and harmful use
Ketamine: hazardous and harmful use
Pregabalin and gabapentin: hazardous, harmful and dependent use
Quetiapine and other antipsychotics: hazardous, harmful and dependent use
Sedating antihistamines: hazardous, harmful and dependent use
Stimulants: hazardous, harmful and dependent use
Volatile inhalants: hazardous, harmful and dependent use
Addictive behaviours
Key resources for substance use and addictive behaviours
Harm reduction in cannabis use
Overview of harm reduction in cannabis use
